ReviewCritical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine2026
The effect of intravenous calcium administration on haemodynamics in perioperative cardiothoracic surgery and intensive care: A narrative review.
Review in Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Calcium plays an essential role in myocardial contractility, excitation-contraction coupling, and vascular tone. In cardiothoracic surgery, calcium supplementation is frequently administered during weaning from cardiopulmonary bypass (CPB) and in the early postoperative period to support haemodynamics. Despite its widespread use, the evidence base underpinning this practice remains limited and inconsistent. This narrative review explores the physiological rationale for calcium supplementation in the cardiothoracic surgical population, synthesises existing experimental and clinical data, and considers potential benefits and risks relevant to contemporary intensive care practice. Animal models suggest that calcium desensitisation contributes to myocardial dysfunction following hypothermic circulatory arrest, with supplementation theoretically improving contractility. In human studies, calcium administration during CPB weaning or in the immediate post-CPB period has been associated with transient increases in mean arterial pressure, systemic vascular resistance and left ventricular stroke work index. However, these effects are short-lived and data beyond the early postoperative phase remains limited. Potential risks of calcium supplementation include exacerbation of ischaemia-reperfusion injury, arrhythmogenesis, graft vasospasm, and tissue injury related to extravasation. The absence of specific guideline recommendations, in contrast to established consensus for vasopressor therapy, likely contributes to international variability in practice. Most studies are small, dated, or proof-of-concept and no high-quality randomised controlled trials have examined patient-centred outcomes such as vasopressor duration, organ dysfunction, or length of stay. Further multicentre observational and target-trial emulation studies are warranted to clarify the role of ionised calcium use in contemporary perioperative and intensive care practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.